Role of Human Liver P450s and Cytochrome b5 in the Reductive Metabolism of 3′-Azido-3′-deoxythymidine (AZT) to 3′-Amino-3′-deoxythymidine

This publication has 26 references indexed in Scilit:

• Cytochrome c oxidase reaction improves histopathological assessment of zidovudine myopathy
  Annals of Neurology, 1993
• AZT Causes Tissue-Specific Inhibition of Mitochondrial Bioenergetic Function
  Biochemical and Biophysical Research Communications, 1993
• Inhibition of mammalian dna polymerase-associated 3′ to 5′ exonuclease activity by 5′-monophosphates of 3′-azido-3′-deoxythymidine and 3′-amino-3′-deoxythymidine
  Biochemical Pharmacology, 1993
• Zidovudine myopathy: A distinctive disorder associated with mitochondrial dysfunction
  Annals of Neurology, 1991
• DNA Polymerases versus HIV Reverse Transcriptase in AIDS Therapy
  Annals of the New York Academy of Sciences, 1990
• Mitochondrial Myopathy Caused by Long-Term Zidovudine Therapy
  New England Journal of Medicine, 1990
• Incorporation of 3’-Azido-3’-deoxythymidine into Cellular DNA and Its Removal in a Human Leukemic Cell Line
  Cancer Communications, 1990
• ZIDOVUDINE-ASSOCIATED MYOPATHY
  The Lancet, 1988
• The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
  New England Journal of Medicine, 1987
• Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.
  Proceedings of the National Academy of Sciences, 1986